Tadao Ishida1, Thomas G.Martin2, Maria-Victoria Mateos3, Niels W.C.J.van de Donk4, Yoshiaki Kuroda5, Zhen Cai6, Weijun Fu7, Alfred L.Garfall8, Ting Niu9, Ajay K.Nooka10, Surbhi Sidana11, Katherine Chastain12, Margaret Doyle13, Kazuko Nishikawa14, Yang Song15, Hiroshi Yamazaki14, Jianmin Zhuo16, Angeline Zhu17, Yusuke Izumi14, Juan Du7, Shinsuke Iida18
1Japanese Red Cross Medical Center, 2University of California, San Francisco, 3University Hospital of Salamanca / IBSAL / CIC / CIBERONC, 4Amsterdam University Medical Center, Vrije Universiteit Amsterdam, 5National Hospital Organization Hiroshima-Nishi Medical Center, 6International College Zhejiang, University West District of Zijingang Campus, 7Shanghai Changzheng Hospital, Naval Medical University, 8Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, 9West China Hospital, Sichuan University, 10Winship Cancer Institute, Emory University, 11Stanford University School of Medicine, 12Janssen Research & Development, 13Janssen Global Services, 14Janssen Pharmaceutical K.K., Research and Development Division, 15Janssen Research & Development, Beijing, China, 16Janssen China Research & Development, 17Janssen Asia Pacific Medical Affairs, 18Nagoya City University Institute of Medical and Pharmaceutical Sciences
International Journal of Myeloma 15(3): 117-117, 2025.